King Wealth Management Group has significantly reduced its position in shares of UnitedHealth Group Incorporated (NYSE: UNH), cutting its holdings by 66.2% during the third quarter of 2023. According to a report from Holdings Channel, the fund now owns 1,263 shares of the healthcare giant after selling 2,478 shares in the same period. The value of King Wealth Management’s stake in UnitedHealth is approximately $436,000, as indicated in its latest filing with the Securities and Exchange Commission (SEC).
Other institutional investors have also made adjustments to their holdings in UnitedHealth Group. For instance, Jacobi Capital Management LLC increased its stake by 16.5%, acquiring an additional 997 shares and raising its total to 7,046 shares, valued at $2,433,000. Similarly, First National Bank of Omaha entered the market with a new investment worth $1,897,000, while Cora Capital Advisors LLC made a new purchase valued at $212,000.
Institutional Investor Activity and Market Performance
In another notable move, Maridea Wealth Management LLC boosted its holdings by an impressive 108.8%, ending the third quarter with 1,487 shares valued at $542,000. Likewise, May Hill Capital LLC increased its stake by 109.0%, acquiring 1,463 shares worth $505,000.
Institutional investors now control 87.86% of UnitedHealth Group’s stock. As of the most recent trading session, shares of UNH opened at $289.04, having fluctuated between a one-year low of $234.60 and a high of $606.36. The company’s market capitalization stands at approximately $261.82 billion, with a price-to-earnings ratio of 21.91.
In terms of financial stability, UnitedHealth Group reports a debt-to-equity ratio of 0.72, a current ratio of 0.79, and a quick ratio of 0.82. The stock’s 50-day moving average is $319.62, while the 200-day moving average is $324.38.
Analysts’ Outlook and Ratings
Market analysts have recently provided insights on UnitedHealth Group’s stock performance. Truist Financial revised its price target from $410.00 to $370.00 while maintaining a “buy” rating. Similarly, Barclays lowered its target from $391.00 to $327.00, also rating the stock as “overweight.” Mizuho adjusted its price estimate from $430.00 to $350.00, assigning an “outperform” rating.
Investor sentiment remains cautiously optimistic, with one analyst issuing a “Strong Buy” rating, seventeen analysts recommending a “Buy,” nine suggesting a “Hold,” and one analyst advising a “Sell.” Based on aggregated data from MarketBeat, UnitedHealth Group holds an average rating of “Moderate Buy,” with a price target of approximately $372.13.
Founded in 1977 and headquartered in Minnetonka, Minnesota, UnitedHealth Group is a diversified healthcare company operating primarily through two divisions: UnitedHealthcare and Optum. The organization offers a wide range of health benefits and services to individuals, employers, and government entities, with operations extending across commercial employer-sponsored plans, Medicare, and Medicaid programs.
For ongoing updates on hedge fund activities and stock performance, investors can refer to Holdings Channel for the latest 13F filings and insider trades related to UnitedHealth Group Incorporated.
